Use of Immunosuppressants/Immunomodulators in Autoimmune/Inflammatory Dermatologic Diseases during COVID-19 Pandemic—General Recommendation Based on Available Evidence

Documenti analoghi

• IADVL Position Statement and Recommendations on Post Lockdown Dermatology Practice Amidst the Covid -19 Pandemic (IADVL Academy and IADVL Executive Committee)
  di: Khurana, Ananta, et al.
  Pubblicazione: (2020)
• Hand Hygiene Practices and Risk and Prevention of Hand Eczema during the COVID-19 Pandemic
  di: Jindal, Rashmi, et al.
  Pubblicazione: (2020)
• Safer Practice of Aesthetic Dermatology during the COVID-19 Pandemic: Recommendations by SIG Aesthetics (IADVL Academy)
  di: Arora, Gulhima, et al.
  Pubblicazione: (2020)
• The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
  di: Reinholz, Markus, et al.
  Pubblicazione: (2021)
• COVID-19 and immunomodulator/immunosuppressant use in dermatology
  di: Price, Kyla N., et al.
  Pubblicazione: (2020)